Co-diagnostics, inc. (CODX)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16
Net sales

214

39

7

-

Net sales

-

-

-

0

Cost of sales

112

9

0

0

Gross profit

102

30

7

0

Operating expenses:
Sales and marketing

1,061

1,165

426

122

Administrative and general

3,497

3,570

3,095

796

Research and development

1,371

1,361

1,003

731

Depreciation and amortization

65

50

45

37

Total operating expenses

5,996

6,148

4,571

1,687

Loss from operations

-5,893

-6,117

-4,564

-1,687

Other expense:
Interest income

36

19

3

-

Interest expense

106

134

310

-

Interest expense

-

-

-

240

Interest income

-

-

-

0

Loss on extinguishment of debt

-

-

-2,072

0

Net loss from investment in joint venture

-

-

-

0

Gain on disposition of assets

0

-

-

-

Gain (loss) on equity method investment in joint venture

-232

-38

-16

-

Total other expense

-301

-153

-2,395

-

Total other expense

-

-

-

240

Loss before income taxes

-6,195

-6,271

-6,959

-1,928

Provision for income taxes

-

-

-

0

Net loss

-6,195

-6,271

-6,959

-1,928

Basic and diluted income (loss) per common share

-0.36

-0.50

-0.63

-

Basic and diluted income (loss) per common share

-

-

-

-0.20

Weighted average common shares outstanding, basic and diluted

16,756

12,484

10,960

9,882